Blister package dispenser
Latest Pfizer Inc. Patents:
- Dosing Regime For Treatment of Chronic Hand Eczema
- Crystalline form of (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3-pyrrolidin]-1-yl]propan-1-one
- Combinations for treatment of NASH/NAFLD and related diseases
- Amorphous Form of (S)-2-(5-((3-Ethoxypyridin-2-YL)Oxy)Pyridin-3-YL)-N-(Tetrahydrofuran-3-YL)Pyrimidine-5-Carboxamide
- Glycoconjugation process
Description
FIG. 1 is a top side perspective view of a blister package dispenser showing my new design;
FIG. 2 is a bottom, left side perspective view of the blister package dispenser shown in FIG. 1; and,
FIG. 3 is a further bottom side perspective view of the blister package dispenser of FIG. 2.
Claims
The ornamental design for a blister package dispenser, as shown and described.
Referenced Cited
Patent History
Patent number: D444056
Type: Grant
Filed: Jan 21, 2000
Date of Patent: Jun 26, 2001
Assignee: Pfizer Inc. (New York, NY)
Inventor: Julian B. Lo (Old Lyme, CT)
Primary Examiner: Raphael Barkai
Attorney, Agent or Law Firms: Peter C. Richardson, Gregg C. Benson, Carl J. Goddard
Application Number: 29/117,364
Type: Grant
Filed: Jan 21, 2000
Date of Patent: Jun 26, 2001
Assignee: Pfizer Inc. (New York, NY)
Inventor: Julian B. Lo (Old Lyme, CT)
Primary Examiner: Raphael Barkai
Attorney, Agent or Law Firms: Peter C. Richardson, Gregg C. Benson, Carl J. Goddard
Application Number: 29/117,364
Classifications
Current U.S. Class:
D9/341
International Classification: 0903;
International Classification: 0903;